Wellomics was founded in 2014 by CEO, Mark Neveu, PhD. a molecular cell biologist with 30+ years of experience in natural health, pharmaceutical, and biologics industries and a track record of over 40 FDA compliant precision wellness products in production today. 

 

Mark's career began at the University of Wisconsin-Madison in the laboratory of Dr. Henry Pitot, the founding Chairman of President Nixon's National Cancer Advisory Board.  After publishing numerous pioneering studies on epigenetic molecular mechanisms of carcinogenesis he went on to be an honorary fellow of the Harvard School of Public Health at the Dana Farber Cancer Institute.

 

For eight further years he supervised a drug discovery laboratory at Pfizer before deciding to focus on what he felt most passionately about: the application of state-of-the-art biophysics and nanotechnology techniques to 

proprietary formulation. Mark, who says that "nature is a better chemist than pharmaceutical companies" now uses his expertise to increase bioavailability ranges from excipient free capsules, complex liquid emulsions and dispersions for natural formulations.